Kenya National Cancer Control Programme (NCCP) FHIR Implementation Guide, published by Digital Health Agency (DHA), Kenya. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/IntelliSOFT-Consulting/nccpFHIRIG/ and changes regularly. See the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: Example Oncology Claim — AC Chemotherapy Cycle 1 Session 1

Raw json | Download

{
  "resourceType" : "Claim",
  "id" : "OncologyClaimExample",
  "meta" : {
    "profile" : [
      🔗 "https://nshr-uat.sha.go.ke/fhir/StructureDefinition/nccp-oncology-claim"
    ]
  },
  "language" : "en",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>SHA insurance claim for Doxorubicin + Cyclophosphamide (AC) cycle 1 session 1 for breast cancer</p></div>"
  },
  "extension" : [
    {
      "url" : "https://nshr-uat.sha.go.ke/fhir/StructureDefinition/nccp-carcinoma-staging-extension",
      "valueCode" : "STAGE-2"
    },
    {
      "url" : "https://nshr-uat.sha.go.ke/fhir/StructureDefinition/nccp-treatment-setting-extension",
      "valueCode" : "DAY-CASE"
    },
    {
      "url" : "https://nshr-uat.sha.go.ke/fhir/StructureDefinition/nccp-session-expected-date-extension",
      "valueDate" : "2026-01-15"
    },
    {
      "url" : "https://nshr-uat.sha.go.ke/fhir/StructureDefinition/nccp-sessions-required-extension",
      "valueInteger" : 8
    },
    {
      "url" : "https://nshr-uat.sha.go.ke/fhir/StructureDefinition/nccp-cost-per-session-extension",
      "valueMoney" : {
        "value" : 15000,
        "currency" : "KES"
      }
    },
    {
      "url" : "https://nshr-uat.sha.go.ke/fhir/StructureDefinition/nccp-regimen-reference-extension",
      "valueReference" : {
        🔗 "reference" : "CarePlan/example-careplan"
      }
    }
  ],
  "status" : "active",
  "type" : {
    "coding" : [
      {
        "system" : "http://terminology.hl7.org/CodeSystem/claim-type",
        "code" : "professional",
        "display" : "Professional"
      }
    ]
  },
  "use" : "preauthorization",
  "patient" : {
    🔗 "reference" : "Patient/example-patient"
  },
  "created" : "2026-01-15",
  "provider" : {
    🔗 "reference" : "Organization/example-organization"
  },
  "priority" : {
    "coding" : [
      {
        "system" : "http://terminology.hl7.org/CodeSystem/processpriority",
        "code" : "normal",
        "display" : "Normal"
      }
    ]
  },
  "diagnosis" : [
    {
      "sequence" : 1,
      "diagnosisReference" : {
        🔗 "reference" : "Condition/example-condition"
      }
    }
  ],
  "insurance" : [
    {
      "sequence" : 1,
      "focal" : true,
      "coverage" : {
        🔗 "reference" : "Coverage/example-coverage"
      }
    }
  ],
  "item" : [
    {
      "sequence" : 1,
      "productOrService" : {
        "coding" : [
          {
            "system" : "https://nshr-uat.sha.go.ke/fhir/CodeSystem/sha-interventions-cs",
            "code" : "SHA-CHEMO-NEO-ADJUVANT",
            "display" : "SHA: Chemotherapy — Neo-adjuvant"
          }
        ]
      },
      "quantity" : {
        "value" : 1
      },
      "unitPrice" : {
        "value" : 15000,
        "currency" : "KES"
      },
      "detail" : [
        {
          "sequence" : 1,
          "productOrService" : {
            "coding" : [
              {
                "system" : "https://nshr-uat.sha.go.ke/fhir/CodeSystem/sha-interventions-cs",
                "code" : "SHA-CHEMO-NEO-ADJUVANT",
                "display" : "SHA: Chemotherapy — Neo-adjuvant"
              }
            ]
          },
          "quantity" : {
            "value" : 1
          },
          "unitPrice" : {
            "value" : 7500,
            "currency" : "KES"
          }
        }
      ]
    }
  ]
}